docEquine Lameness & Regenerative Medicine Workshop
download 
Report Transcription
Your partners in regenerative medicine Equine Lameness & Regenerative Medicine Workshop (CPD) Wednesday 22nd April 2015 Location: Lingehoeve Diergeneeskunde Veldstraat 3a, 4033 AK Lienden, Netherlands This day will focus on the pathology, imaging and treatment strategies, including the use of regenerative medicine. Understanding the pathology, timing and development of the disease process linked to diagnostic findings will enable the clinician to apply the choice of treatment more accurately with better outcome. The timetable is outlined below: 08.30 -‐ 09.00 Welcome and registration 09.00 -‐ 09.15 Opening Equine Lameness & Regenerative Medicine Workshop 09.15 -‐ 10.15 Pathology of common equine tendon, ligament and joint disease Dr Henk van der Veen DVM COFFEE BREAK 10.30 -‐ 11.15 Examination procedure Evita Busschers DVM MVR DipACVS MRCVS DipACVSMR 11.15 -‐ 12.15 Diagnostic imaging of equine tendon, ligament and joints (radiography, ultrasonography, MRI and other imaging modalities) Ben Anghileri BVetMed MRCVS 12.15 – 13.00 Conventional treatments for tendon, ligament and joint disease -‐ what are the options? (surgical options, HA, PPS, PSGAGs, NSAIDs, controlled exercise etc.) Evita Busschers DVM MVR DipACVS MRCVS DipACVSMR LUNCH 14.00 – 14.45 Use of regenerative medicine -‐ when, what and how? (stem cells, PRP, IRAP/ACS & BMAC) Greg McGarrell 14.45 – 17.30 Practical demonstrations to include: Limb injections and scanning (Ben Anghileri) Live horse demo taking bone marrow (Greg McGarrell) Lameness work-‐up (Evita Busschers) And a coffee break! Cost per delegate -‐ €250,-‐ (excl. 21% VAT) Number of participants: max. 30 Accreditation: KD will be requested To book please visit www.nupsala.com or send an email to [email protected] If there are any questions, do not hesitate to contact us: Bianca Verhoeven -‐ +31 (0)6 51 52 39 93 – [email protected] Lucy Graham -‐ +44 (0)79 79 64 67 65 -‐ [email protected] This day will be organised by Nupsala Veterinary Services in partnership with VVDB Zeeland and Lingehoeve Diergeneeskunde. www.nupsala.com www.vvdb-‐zeeland.nl www.delingehoeve.nl
Similar documents
Market Overview – Regenerative Medicine Market Shares, Strategies And Forecasts to 2023: Credence Research
Credence Research has recently issued a new market assessment report titled “Regenerative Medicine – Growth, Future Prospects and Competitive Analysis, 2016 – 2022”. The global Regenerative Medicine Market study provides a comprehensive view of the ongoing and future phases of the Regenerative Medicine industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution.
Browse the report at http://www.credenceresearch.com/report/regenerative-medicine-market
Based on geographic/regional distribution the global Regenerative Medicine Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Regenerative Medicine Market based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa markets. Among these, the North America, Europe and Asia-Pacific Regenerative Medicine Market is studied for top country-level markets. The Regenerative Medicine industry in each individual country market is studied based on parameters such as per capita income, population, gross domestic product (GDP), status of infrastructure, purchasing power parity, etc. Technology development, industry concentration, end-user preference, and similar such grounds are also considered while estimating the market for Regenerative Medicine. The market estimates are provided for the period 2014-2022, along with corresponding compounded annual growth rates (CAGRs) for the forecast period 2016-2022.
Request Table of content - http://www.credenceresearch.com/request-table-of-content/58213
This report on Regenerative Medicine Market also offers competition assessment tools such as market positioning of key players, attractive investment proposition, and Porter’s Five Forces model to give the readers a view of the competitive scenario of the Regenerative Medicine Market. The Regenerative Medicine Market report is concluded with company profiles chapter. This section highlights major information about the key players engaged in development, manufacture, distribution and sale of Regenerative Medicine in the international markets.
Request free sample - http://www.credenceresearch.com/sample-request/58213
Major extracts from the Table of Content of Regenerative Medicine Market, 2016-2022 report:
Regenerative Medicine Market Dynamics – Drivers, Challenges, Opportunities
Regenerative Medicine Market Size and Forecast for the Period 2014-2022
Regenerative Medicine Market CAGR for the Period 2016-2022
Regenerative Medicine Market Competitive Analysis, by Key Players
Regenerative Medicine Market: Attractive Investment Proposition, by Geography
Regenerative Medicine Market: Key Commercial Events
Regenerative Medicine Market: Future Prospects (upcoming product approvals)
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: [email protected]
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com
Global Regenerative Medicine Market
Regenerative medicine is a category of research in tissue engineering and molecular biology which deals with the method for human cells, tissues and organs reco nstruction to reactivate normal body function. The regenerative medicine repairs the defective cells and tissues. Regenerative medicine treats the basic cause of disease, injuries and genetic conditions. Regenerative medicine gives complete treatment of the abnormality or disease as compared to the symptomatic treatments. Regenerative medicine is a treatment technique which works in three approaches which ensure the complete eradication of the injury of the cell, tissue or organ. There are stem cells and non-stem cell (somatic) therapies which includes taking cells from healthy body organ in the body and applying these cells to the damaged area after expanding these cells in cell culture.
Global Regenerative Therapies Market, 2016 to 2022
The global regenerative therapies market has been estimated to be valued at US$ 5,286.2 Mn by the end of 2015, and is projected to witness stable growth across all global regions, which is attributed to the rising demand for fulfilling unmet clinical needs for longer sustainability and faster outcome treatments within a shorter time span.
